Literature DB >> 30842059

Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group.

Bianca A Hoeben1, Christian Carrie2, Beate Timmermann3, Henry C Mandeville4, Lorenza Gandola5, Karin Dieckmann6, Monica Ramos Albiac7, Henriette Magelssen8, Yasmin Lassen-Ramshad9, Barbora Ondrová10, Thankamma Ajithkumar11, Claire Alapetite12, Brian V Balgobind13, Stephanie Bolle14, Alison L Cameron15, Raquel Davila Fajardo16, Stefan Dietzsch17, Delphine Dumont Lecomte18, Marry M van den Heuvel-Eibrink19, Rolf D Kortmann17, Anne Laprie20, Patrick Melchior21, Laetitia Padovani22, Barbara Rombi23, Giovanni Scarzello24, Rudolf Schwarz25, Klaus Seiersen9, Enrica Seravalli26, Nicola Thorp27, Gillian A Whitfield28, Tom Boterberg29, Geert O Janssens16.   

Abstract

Inhomogeneities in radiotherapy dose distributions covering the vertebrae in children can produce long-term spinal problems, including kyphosis, lordosis, scoliosis, and hypoplasia. In the published literature, many often interrelated variables have been reported to affect the extent of potential radiotherapy damage to the spine. Articles published in the 2D and 3D radiotherapy era instructed radiation oncologists to avoid dose inhomogeneity over growing vertebrae. However, in the present era of highly conformal radiotherapy, steep dose gradients over at-risk structures can be generated and thus less harm is caused to patients. In this report, paediatric radiation oncologists from leading centres in 11 European countries have produced recommendations on how to approach dose coverage for target volumes that are adjacent to vertebrae to minimise the risk of long-term spinal problems. Based on available information, it is advised that homogeneous vertebral radiotherapy doses should be delivered in children who have not yet finished the pubertal growth spurt. If dose fall-off within vertebrae cannot be avoided, acceptable dose gradients for different age groups are detailed here. Vertebral delineation should include all primary ossification centres and growth plates, and therefore include at least the vertebral body and arch. For partial spinal radiotherapy, the number of irradiated vertebrae should be restricted as much as achievable, particularly at the thoracic level in young children (<6 years old). There is a need for multicentre research on vertebral radiotherapy dose distributions for children, but until more valid data become available, these recommendations can provide a basis for daily practice for radiation oncologists who have patients that require vertebral radiotherapy.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30842059     DOI: 10.1016/S1470-2045(19)30034-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  12 in total

1.  Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.

Authors:  Shunsuke Suzuki; Takahiro Kato; Masao Murakami
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

Review 2.  Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.

Authors:  Chia-Ho Hua; Anthony E Mascia; Enrica Seravalli; Antony J Lomax; Klaus Seiersen; Kenneth Ulin
Journal:  Pediatr Blood Cancer       Date:  2021-05       Impact factor: 3.167

3.  Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.

Authors:  Stefan Dietzsch; Annett Braesigk; Clemens Seidel; Julia Remmele; Ralf Kitzing; Tina Schlender; Martin Mynarek; Dirk Geismar; Karolina Jablonska; Rudolf Schwarz; Montserrat Pazos; Marc Walser; Silke Frick; Kristin Gurtner; Christiane Matuschek; Semi Ben Harrabi; Albrecht Glück; Victor Lewitzki; Karin Dieckmann; Martin Benesch; Nicolas U Gerber; Stefan Rutkowski; Beate Timmermann; Rolf-Dieter Kortmann
Journal:  Strahlenther Onkol       Date:  2020-11-23       Impact factor: 3.621

4.  Chronological Analysis of Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors.

Authors:  Gyu Sang Yoo; Jeong Il Yu; Sungkoo Cho; Youngyih Han; Yoonjin Oh; Do Hoon Lim; Hee Rim Nam; Ji-Won Lee; Ki-Woong Sung; Hyung Jin Shin
Journal:  Cancer Res Treat       Date:  2021-10-15       Impact factor: 5.036

5.  An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric Cancer.

Authors:  Keiichiro Baba; Masashi Mizumoto; Yoshiko Oshiro; Shosei Shimizu; Masatoshi Nakamura; Yuichi Hiroshima; Takashi Iizumi; Takashi Saito; Haruko Numajiri; Kei Nakai; Hitoshi Ishikawa; Toshiyuki Okumura; Kazushi Maruo; Hideyuki Sakurai
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

6.  Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors.

Authors:  Joeri Mul; Enrica Seravalli; Mirjam E Bosman; Cornelis P van de Ven; Annemieke S Littooij; Martine van Grotel; Marry M van den Heuvel-Eibrink; Geert O Janssens
Journal:  Clin Transl Radiat Oncol       Date:  2021-05-03

7.  Triggered kV Imaging During Spine SBRT for Intrafraction Motion Management.

Authors:  Jihye Koo; Louis Nardella; Michael Degnan; Jacqueline Andreozzi; Hsiang-Hsuan M Yu; Jose Penagaricano; Peter A S Johnstone; Daniel Oliver; Kamran Ahmed; Stephen A Rosenberg; Evan Wuthrick; Roberto Diaz; Vladimir Feygelman; Kujtim Latifi; Eduardo G Moros; Gage Redler
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 8.  Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life.

Authors:  Tamara Diesch-Furlanetto; Melissa Gabriel; Olga Zajac-Spychala; Alessandro Cattoni; Bianca A W Hoeben; Adriana Balduzzi
Journal:  Front Pediatr       Date:  2021-11-24       Impact factor: 3.418

Review 9.  Proton versus Photon Radiotherapy for Pediatric Central Nervous System Malignancies: A Systematic Review and Meta-Analysis of Dosimetric Comparison Studies.

Authors:  Roberta Carbonara; Alessia Di Rito; Angela Monti; Giuseppe Rubini; Angela Sardaro
Journal:  J Oncol       Date:  2019-11-27       Impact factor: 4.375

10.  Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation.

Authors:  D Wegener; P Lang; F Paulsen; N Weidner; D Zips; M Ebinger; U Holzer; M Döring; F Heinzelmann
Journal:  Strahlenther Onkol       Date:  2021-09-02       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.